“alkermes” Archives

in
Entry Author Date Location
FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats 10/09/20 Europe
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More 12/13/19 National
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Alkermes Eyes Brain Disorders and Beyond With $100M Deal for Rodin 11/18/19 Boston
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It? 10/10/19 National
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Biogen, Taking Its Crisis “Seriously,” Keeps Focus on Neuroscience 04/24/19 Boston
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
FDA Rejects Alkermes Depression Drug, Asks for More Clinical Data 02/01/19 Boston
Alkermes Schizophrenia Drug Heads To FDA, But Questions Linger 11/29/18 Boston
Expansion Therapeutics Hires Elliot Enrich as CMO 11/13/18 San Diego
Bio Roundup: Depression Drug Dashed, Peek at ASH, CRISPR Worry & More 11/02/18 National
Alkermes Depression Drug Faces Long Odds After FDA Advisors Say No 11/01/18 Boston
FDA Blasts Data, Trial Design For Alkermes Depression Drug 10/30/18 Boston
With $1.6B Armo Buy, Eli Lilly Is the Latest to Bet Big on Cytokines 05/10/18 Indiana
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
Alkermes Depression Drug Review Goes Ahead After FDA About-Face 04/16/18 Boston
Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More 04/06/18 National
FDA Refuses Review of Alkermes Depression Drug, Wants More Trials 04/02/18 Boston
Sage Shares Soar Again As Depression Drug Hits Mark in Phase 2 Test 12/07/17 Boston
15 For ’18: Key Clinical Data to Watch For Next Year (Part 2) 12/06/17 National
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
Bio Roundup: Drug Price Debates, NY Bio Blooms & CEOs Take Social Stand 08/25/17 National
Side Effect Weighs on Early Results for Alkermes’ Schizophrenia Drug 06/29/17 Boston
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
Stifling Immigration Is “Retrograde”: Highlights From “What’s Hot” 05/17/17 Boston
On Tap For “What’s Hot” on May 11: Opioid Crisis, Immigration & More 04/13/17 Boston
Check Out What’s Hot in Boston Biotech on May 11: Saver Rate Ends Today 04/06/17 Boston
Page 1 of 8 next page »